Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation

BACKGROUND: There is an acknowledged lack of robust and rigorous research focusing on the perspectives of those prescribing direct acting oral anticoagulants (DOACs) for non-valvular atrial fibrillation (AF). OBJECTIVE: The objective was to describe prescribers’ experiences of using DOACs in the man...

Descripción completa

Detalles Bibliográficos
Autores principales: Generalova, Daria, Cunningham, Scott, Leslie, Stephen J., Rushworth, Gordon F., Mciver, Laura, Stewart, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308911/
https://www.ncbi.nlm.nih.gov/pubmed/32587643
http://dx.doi.org/10.18549/PharmPract.2020.2.1936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308911/
https://www.ncbi.nlm.nih.gov/pubmed/32587643
http://dx.doi.org/10.18549/PharmPract.2020.2.1936

Ejemplares similares